Vintor 4000 Injection (Recombinant Erythropoietin Alfa)

Vintor 4000 Injection

Vintor 4000 IU Injection is a synthetic form of a protein that regulates the formation of red blood cells in the body. It is used to treat anemia caused due to severe kidney disease or cancer medications. It is also used during certain surgeries to decrease the need for blood transfusion.

Substitutes

List of substitutes for Vintor 4000 IU Injection
Epofer 4000 IU Injection
Emcure Pharmaceuticals Ltd.
Eposis 4000 IU Injection
Micro Labs Ltd.
Epotrust 4000 IU Injection
Panacea Biotec Ltd.
Erypro 4000 IU Injection
Biocon Ltd.
Repoitin 4000 IU Injection
Serum Institute Of India Ltd.

Side effects

Major & minor side effects for Vintor 4000 IU Injection
Fever
Nausea
Vomiting
Mouth sores
Headache
Muscle or joint pain
Cough
Diarrhea
Swelling and redness at the injection site
Stomach discomfort and pain
Severe skin allergy
Swelling of face, lips, eyelids, tongue, hands and feet
Difficulty in breathing
Wheezing
Dizziness and fainting
Upper respiratory tract infection
Difficulty in swallowing
Increased blood pressure
Pure red cell aplasia

Uses of Vintor 4000 IU Injection

What is it prescribed for?
Chronic kidney disease associated anemia
Vintor 4000 IU Injection is used to treat anemia in patients having chronic kidney diseases.
Chemotherapy associated anemia
Vintor 4000 IU Injection is used to treat anemia associated with the use of chemotherapy medicines to treat certain specific types of cancer.
Anemia due to use of medicines
Vintor 4000 IU Injection is used to treat anemia associated with the use of Zidovudine to treat HIV infection.
Anemia associated with surgery
Vintor 4000 IU Injection is also used before and after certain surgeries where chances of significant blood loss is high. It reduces the dependency on blood transfusion process.

Related Product

Vintor 2000IU Injection
Vintor 4000 Injection
Vintor 6000IU Injection
Vintor 10000IU Injection

When not to use?

Allergy
This medicine is not recommended for use if you have a history of allergy to epoetin alfa or albumin or any other ingredient present in the dosage form.
Non-chemotherapy associated anemia in cancer patients
This medicine is not recommended for use to treat anemia in cancer patients who are are not receiving any chemotherapy medication.
High blood pressure
This medicine is not recommended for use in patients who have high blood pressure and are not taking any medicine to control it.
Pure red cell aplasia
This medicine is not recommended for use if the patient has had a history of pure red cell aplasia after using this medicine or other medicines belonging to the Eryhtropoietin class of drugs.
Use of multi-dose vials
Use of multi-dose vials of this medicine is not recommended for children or pregnant women. The risk of severe adverse effects are increasingly high in such cases.

Warnings

Warnings for special population
Pregnancy
Use of this medicine is not recommended for pregnant women unless absolutely necessary. All the potential benefits and risks should be considered before administering this medicine. Use of this medicine containing benzyl alcohol as an ingredient and use of multi-dose vial is not recommended for pregnant women.
Breast-feeding
Use of this medicine is not recommended for women who are breastfeeding an infant unless absolutely necessary. The use of benzyl alcohol containing dosage forms or multi-dose vials are not recommended.
General warnings
Not for immediate effect
This medicine should not be used in cases where an immediate increase in red blood cell count is desired.
Ongoing cancer treatment
This medicine is not recommended for use in patients who are being treated with biological or radiological medications. It is also not recommended for use in patients who are receiving myelosuppressive therapy for a curable form of cancer.
Surgery of heart and blood vessels
This medicine is not recommended for use in patients who are about to have a surgery of the heart or blood vessels.
Autologous blood donation before surgery
This medicine is not recommended for use in patients who are giving their own blood for transfusion before surgery.
Heart and blood vessel disorders
This medicine should be used with caution since it can cause severe to fatal adverse effects especially in patients suffering from a pre-existing condition of the heart and blood vessels.
Seizures
This medicine can cause seizures in patients suffering from a kidney disorder especially in the early stages of treatment. All such patients should be dosed carefully with appropriate monitoring.
Other ingredients
This medicine may contain benzyl alcohol or albumin which increases the risk of certain adverse effects and hence should be carefully administered.
Multi-dose vials
Use of multi-dose vials or vials containing benzyl alcohol is not recommended for small children.

Dosage

Missed Dose
Contact your doctor if you have missed a scheduled dose of this medicine and follow all the instructions given.
Overdose
Contact your doctor immediately if an overdose is suspected.

Interactions

All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol
Description
Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Instructions
Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine
Ramipril
Cyclosporine
Thalidomide
Disease interactions
Hypertension
This medicine should be used with caution in patients with elevated blood pressure levels especially if it is uncontrolled. Your doctor will ensure that the blood pressure is under control before the use of epoetin alfa starts.
Seizure disorders
This medicine should be used with caution in patients suffering from seizure disorders as the risk of adverse effects are significantly high. You may require clinical monitoring at least in the early stages of treatment with epoetin alfa.
Blood clotting disorders
This medicine should be used with extreme caution in patients with blood clotting disorders since the risks of severe adverse effects are very high. Any disease of the heart and blood vessels should be reported to the doctor before treatment with epoetin alfa is initiated.
Hemodialysis
This medicine should be administered with caution in patients undergoing hemodialysis. Suitable dose adjustment and clinical monitoring is recommended while giving this medicine.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.

General Instructions

Take Vintor 4000 IU Injection alfa as instructed by the doctor and adhere to the dosage changes made in the course of treatment. It is advised to take this medication in the presence of a trained healthcare professional.